Prevention and remission of diabetic nephropathy

Taro Sugimoto, Yoshio Nakamura, Hirofumi Makino

Research output: Contribution to journalReview article

Abstract

Diabetic nephropathy is the most important cause of end-stage renal failure. Recent clinical trials have postulated the possibility for prevention and remission of the disease once reckoned as irreversible. In DCCT, UKPDS and Kumamoto study, progression to overt proteinuria was prevented by intensive blood glucose control. Lewis study has demonstrated renoprotective effect of ACE inhibitor in type-1 diabetic nephropathy, and RENAAL and IDNT has documented that of angiotensin II type-1 receptor blocker in type-2 diabetes. Moreover, potential efficacy of lipid lowering in prevention of diabetic nephropathy has been postulated in recent Steno-2, multifactorial intervention trial. Thus, simultaneous adjustment on hyperglycemia, hypertension, and dyslipidemia may lead to prevention and remission of diabetic nephropathy.

Original languageEnglish
Pages (from-to)1167-1171
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Volume61
Issue number7
Publication statusPublished - Jan 1 2003

Fingerprint

Diabetic Nephropathies
Angiotensin II Type 1 Receptor Blockers
Dyslipidemias
Proteinuria
Angiotensin-Converting Enzyme Inhibitors
Hyperglycemia
Type 2 Diabetes Mellitus
Chronic Kidney Failure
Blood Glucose
Clinical Trials
Hypertension
Lipids

Cite this

Prevention and remission of diabetic nephropathy. / Sugimoto, Taro; Nakamura, Yoshio; Makino, Hirofumi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 61, No. 7, 01.01.2003, p. 1167-1171.

Research output: Contribution to journalReview article

Sugimoto, Taro ; Nakamura, Yoshio ; Makino, Hirofumi. / Prevention and remission of diabetic nephropathy. In: Nippon rinsho. Japanese journal of clinical medicine. 2003 ; Vol. 61, No. 7. pp. 1167-1171.
@article{f644d1e89ee04f1abdb0b215bd9e6169,
title = "Prevention and remission of diabetic nephropathy",
abstract = "Diabetic nephropathy is the most important cause of end-stage renal failure. Recent clinical trials have postulated the possibility for prevention and remission of the disease once reckoned as irreversible. In DCCT, UKPDS and Kumamoto study, progression to overt proteinuria was prevented by intensive blood glucose control. Lewis study has demonstrated renoprotective effect of ACE inhibitor in type-1 diabetic nephropathy, and RENAAL and IDNT has documented that of angiotensin II type-1 receptor blocker in type-2 diabetes. Moreover, potential efficacy of lipid lowering in prevention of diabetic nephropathy has been postulated in recent Steno-2, multifactorial intervention trial. Thus, simultaneous adjustment on hyperglycemia, hypertension, and dyslipidemia may lead to prevention and remission of diabetic nephropathy.",
author = "Taro Sugimoto and Yoshio Nakamura and Hirofumi Makino",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "61",
pages = "1167--1171",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "7",

}

TY - JOUR

T1 - Prevention and remission of diabetic nephropathy

AU - Sugimoto, Taro

AU - Nakamura, Yoshio

AU - Makino, Hirofumi

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Diabetic nephropathy is the most important cause of end-stage renal failure. Recent clinical trials have postulated the possibility for prevention and remission of the disease once reckoned as irreversible. In DCCT, UKPDS and Kumamoto study, progression to overt proteinuria was prevented by intensive blood glucose control. Lewis study has demonstrated renoprotective effect of ACE inhibitor in type-1 diabetic nephropathy, and RENAAL and IDNT has documented that of angiotensin II type-1 receptor blocker in type-2 diabetes. Moreover, potential efficacy of lipid lowering in prevention of diabetic nephropathy has been postulated in recent Steno-2, multifactorial intervention trial. Thus, simultaneous adjustment on hyperglycemia, hypertension, and dyslipidemia may lead to prevention and remission of diabetic nephropathy.

AB - Diabetic nephropathy is the most important cause of end-stage renal failure. Recent clinical trials have postulated the possibility for prevention and remission of the disease once reckoned as irreversible. In DCCT, UKPDS and Kumamoto study, progression to overt proteinuria was prevented by intensive blood glucose control. Lewis study has demonstrated renoprotective effect of ACE inhibitor in type-1 diabetic nephropathy, and RENAAL and IDNT has documented that of angiotensin II type-1 receptor blocker in type-2 diabetes. Moreover, potential efficacy of lipid lowering in prevention of diabetic nephropathy has been postulated in recent Steno-2, multifactorial intervention trial. Thus, simultaneous adjustment on hyperglycemia, hypertension, and dyslipidemia may lead to prevention and remission of diabetic nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=0141613739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141613739&partnerID=8YFLogxK

M3 - Review article

VL - 61

SP - 1167

EP - 1171

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 7

ER -